NOVARTIS

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R.5547/S. 476 - Maintaining Investments in New Innovation Act.

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340B Drug Pricing Program; Issues related to drug pricing; Issues related to pharmacy benefit managers.